RDY vs. IBN
RDY (Dr. Reddy's Laboratories Limited) and IBN (ICICI Bank Limited) are both stocks. RDY operates in Drug Manufacturers - Specialty & Generic (Healthcare), while IBN operates in Banks - Regional (Financial Services). Over the past 10 years, RDY returned 4.12%/yr vs 15.33%/yr for IBN. At a 0.33 correlation, their price movements are largely independent.
Performance
RDY vs. IBN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RDY achieves a -7.26% return, which is significantly higher than IBN's -14.43% return. Over the past 10 years, RDY has underperformed IBN with an annualized return of 4.12%, while IBN has yielded a comparatively higher 15.33% annualized return.
RDY
- 1D
- -0.08%
- 1M
- -2.47%
- YTD
- -7.26%
- 6M
- -7.86%
- 1Y
- -10.63%
- 3Y*
- 5.64%
- 5Y*
- -1.06%
- 10Y*
- 4.12%
IBN
- 1D
- 0.87%
- 1M
- -2.45%
- YTD
- -14.43%
- 6M
- -16.97%
- 1Y
- -23.64%
- 3Y*
- 4.21%
- 5Y*
- 8.01%
- 10Y*
- 15.33%
RDY vs. IBN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RDY Dr. Reddy's Laboratories Limited | -7.26% | -10.53% | 14.13% | 36.47% | -19.74% | -7.33% | 76.80% | 8.45% | 0.37% | -16.46% |
IBN ICICI Bank Limited | -14.43% | 0.57% | 26.32% | 9.80% | 11.27% | 33.57% | -1.52% | 47.01% | 6.25% | 44.03% |
Correlation
The correlation between RDY and IBN is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.30 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.30 |
Correlation (All Time) Calculated using the full available price history since Apr 12, 2001 | 0.33 |
Fundamentals
RDY:
$10.87B
IBN:
$92.40B
RDY:
$51.45
IBN:
$149.87
RDY:
0.25
IBN:
0.17
RDY:
0.01
IBN:
0.01
RDY:
0.03
IBN:
0.03
RDY:
0.03
IBN:
0.03
RDY:
$337.10B
IBN:
$3.13T
RDY:
$177.79B
IBN:
$2.18T
RDY:
$74.65B
IBN:
$774.07B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RDY vs. IBN — Risk / Return Rank
RDY
IBN
RDY vs. IBN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dr. Reddy's Laboratories Limited (RDY) and ICICI Bank Limited (IBN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RDY | IBN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.72 | ||
| Sortino ratioReturn per unit of downside risk | +1.20 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 0.80 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | -0.48 | -0.91 | +0.43 |
| Martin ratioReturn relative to average drawdown | -0.82 | -1.79 | +0.97 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RDY | IBN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.45 | -1.17 | +0.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.34 | -0.39 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.16 | 0.49 | -0.33 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.23 | +0.13 |
Drawdowns
RDY vs. IBN - Drawdown Comparison
The maximum RDY drawdown since its inception was -60.62%, smaller than the maximum IBN drawdown of -86.09%. Use the drawdown chart below to compare losses from any high point for RDY and IBN.
Loading charts...
Drawdown Indicators
| RDY | IBN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -60.62% | -86.09% | +25.47% |
Max Drawdown (1Y)Largest decline over 1 year | -22.46% | -26.20% | +3.74% |
Max Drawdown (3Y)Largest decline over 3 years | -26.61% | -26.20% | -0.41% |
Max Drawdown (5Y)Largest decline over 5 years | -35.25% | -26.24% | -9.01% |
Max Drawdown (10Y)Largest decline over 10 years | -47.13% | -55.05% | +7.92% |
Current DrawdownCurrent decline from peak | -22.21% | -25.32% | +3.11% |
Average DrawdownAverage peak-to-trough decline | -21.93% | -28.01% | +6.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.00% | 13.22% | -0.22% |
Volatility
RDY vs. IBN - Volatility Comparison
Dr. Reddy's Laboratories Limited (RDY) has a higher volatility of 9.37% compared to ICICI Bank Limited (IBN) at 6.04%. This indicates that RDY's price experiences larger fluctuations and is considered to be riskier than IBN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RDY | IBN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.37% | 6.04% | +3.33% |
Volatility (6M)Calculated over the trailing 6-month period | 17.46% | 16.32% | +1.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.79% | 20.29% | +3.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.28% | 23.59% | -0.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.60% | 31.68% | -5.08% |
Dividends
RDY vs. IBN - Dividend Comparison
RDY's dividend yield for the trailing twelve months is around 0.70%, less than IBN's 0.98% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBN ICICI Bank Limited | 0.98% | 0.84% | 0.80% | 0.81% | 0.57% | 0.27% | 0.00% | 0.19% | 0.43% | 0.79% | 1.98% | 4.01% |
RDY Dr. Reddy's Laboratories Limited | 0.70% | 0.65% | 0.60% | 1.39% | 1.48% | 1.04% | 0.46% | 0.71% | 0.00% | 0.78% | 0.62% | 0.63% |
Financials
RDY vs. IBN - Financials Comparison
This section allows you to compare key financial metrics between Dr. Reddy's Laboratories Limited and ICICI Bank Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
RDY vs. IBN - Profitability Comparison
RDY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a gross profit of 34.22B and revenue of 76.33B. Therefore, the gross margin over that period was 44.8%.
IBN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ICICI Bank Limited reported a gross profit of 623.06B and revenue of 846.14B. Therefore, the gross margin over that period was 73.6%.
RDY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported an operating income of 473.25M and revenue of 76.33B, resulting in an operating margin of 0.6%.
IBN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ICICI Bank Limited reported an operating income of 208.13B and revenue of 846.14B, resulting in an operating margin of 24.6%.
RDY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dr. Reddy's Laboratories Limited reported a net income of 2.24B and revenue of 76.33B, resulting in a net margin of 2.9%.
IBN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ICICI Bank Limited reported a net income of 147.55B and revenue of 846.14B, resulting in a net margin of 17.4%.
Frequently Asked Questions
RDY and IBN have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RDY has higher volatility (9.37%) compared to IBN (6.04%). In terms of maximum drawdown, RDY dropped -60.62% vs IBN's -86.09%.
RDY currently has the higher Sharpe Ratio (-0.45 vs -1.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RDY and IBN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer